From Ella Danilovich
Y. Lynn Wang, MD, PhD
Professor of PathologyDirector, Laboratory of Lymphoma Translational PathologyUniversity of ChicagoTitle: "Ibrutinib resistance in CLL and exploration of alternative therapies"